Carna Biosciences Inc
TSE:4572
Carna Biosciences Inc
TSE:4572
Price:
441 JPY
6.01%
Market Closed
Updated:
May 9, 2024
Carna Biosciences Inc
Income from Continuing Operations
|
Carna Biosciences Inc
Income from Continuing Operations Peer Comparison
Comparables:
2309
2370
4880
2183
7079
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Carna Biosciences Inc
TSE:4572
|
Income from Continuing Operations
-¥1.2B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-15%
|
|
|
CMIC Holdings Co Ltd
TSE:2309
|
Income from Continuing Operations
¥5.6B
|
CAGR 3-Years
63%
|
CAGR 5-Years
30%
|
CAGR 10-Years
15%
|
|
|
Medinet Co Ltd
TSE:2370
|
Income from Continuing Operations
-¥1.4B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-11%
|
|
|
CellSource Co Ltd
TSE:4880
|
Income from Continuing Operations
¥923.1m
|
CAGR 3-Years
50%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
Linical Co Ltd
TSE:2183
|
Income from Continuing Operations
¥680.4m
|
CAGR 3-Years
41%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
4%
|
|
|
WDB coco Co Ltd
TSE:7079
|
Income from Continuing Operations
¥743.6m
|
CAGR 3-Years
34%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
See Also
What is Carna Biosciences Inc's Income from Continuing Operations?
Income from Continuing Operations
-1.2B
JPY
-1.2B
JPY
Based on the financial report for Dec 31, 2023, Carna Biosciences Inc's Income from Continuing Operations amounts to -1.2B JPY.
What is Carna Biosciences Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-15%
-15%
Over the last year, the Income from Continuing Operations growth was 15%. The average annual Income from Continuing Operations growth rates for Carna Biosciences Inc have been -1% over the past three years , 1% over the past five years , and -15% over the past ten years .
You don't have any saved screeners yet
